ATP6AP1 and breast cancer: On the other hand, BC patients with higher ATP6AP1 levels had poorer prognoses if they had enriched basophil levels, reduced CD8+ T cell levels or reduced Treg levels (all P < 0.05), but not if they had reduced basophil levels, enriched CD8+ T cell levels or enriched Treg levels.